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Few studies have investigated outpatient preferences for the communication of results. 4 We examined preferences for skin biopsy result communication for benign, nonelife-threatening malignant, and lifethreatening malignant diagnoses in a consecutive sample of dermatology outpatients. Our study found black and white patients had different preferences for skin biopsy result communication.
After institutional review board approval, this cross-sectional study was performed at Emory Dermatology Clinics in 2015. All English-speaking patients [18 years of age were eligible. The final survey, revised from a pilot survey vetted by [ 100 patients and nonmedical personnel, assessed patient demographics, history of skin cancer or biopsy, and experience with patient portals. Preferences on result communication method was assessed for benign noncancerous (PrefBen), nonelife-threatening skin cancer (PrefNMSC), and life-threatening skin cancer (PrefMel). Communication modalities included face-to-face (FTF), telephone, and portalbased electronic messaging.
Statistical analyses were performed by using SAS software 9 (SAS Institute Inc, Cary, NC). Descriptive statistics and a generalized linear model was used for continuous variables and chi-squared analyses for categorical variables. Predictor factors for biopsy communication preference were explored by using logistic regression models.
In total, 551 consecutive patients were eligible, of whom 500 completed surveys (response rate 91%). Mean age was 49 years (standard deviation 20.0 years), and 66.4% were white, 25.5% black, and 8.1% other races (Table I) . Patient preferences for communication method by race are shown in Table II . Univariate analyses included race; age; sex; education; distance from clinic; and frequency of skin biopsy, skin cancer, portal communication, and previous electronic result delivery. Univariate analyses for PrefBen showed significance for race (P \.001), education (P ¼ .004), and previous portal usage (P \ .001). Race (P \ .001), history of skin cancer (P ¼ .019), and previous portal usage (P \ .001) were significant for PrefNMSC. Race (P \ .001), education (P ¼ .006), history of skin cancer (P ¼ .035), and previous portal usage (P \ .001) were significant for PrefMel. Only race and previous portal use were independently predictive of PrefBen, PrefNMSC, and PrefMel after adjusting for variables significant in univariate analyses (Supplemental Table I ; available at http://www.jaad. org).
Black and white patients preferred telephone versus other communication modalities for benign and nonelife-threatening malignant results. However, black patients preferred face-to-face for malignant diagnoses (Table II) Table I ). Independent of demographics, patients with portal communication experience were more amenable to electronic messaging (Supplemental Table I ).
Our study found blacks were more likely to prefer face-to-face communication for biopsy results compared with other racial groups. Studies have shown that blacks compared with other racial groups are more dissatisfied with physician communication, reporting larger unmet information needs 2, 4 and inadequate discussions about treatment options. 5 Electronic communication, which decreases inperson time between patients and physicians, might exacerbate these concerns.
Limitations of this study include conducting the study at a single site with a single subspecialty and having small numbers of nonblack minority patients. Strengths of this study include its large sample size, larger proportion of black patients compared with previous studies, and high response rate.
Dermatological health care providers should recognize that preferences for how skin biopsy results are communicated might be influenced by characteristics of the patient, including race. Further investigation is needed to confirm and better understand the basis of racial differences in result communication preferences. 
